Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32523109.
- Also identified by DOI 10.1038/s41467-020-16779-4 and PMC identifier 7286911.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Amid the COVID-19 pandemic, scientists around the globe have been working resolutely to find therapies to treat patients and avert the spreading of the SARS-CoV-2 virus. In this commentary, we highlight some of the latest studies that provide atomic-resolution structural details imperative for the development of vaccines and antiviral therapeutics.
Medical subject headings
- Antiviral Agents
- Betacoronavirus
- Coronavirus Infections
- Pneumonia, Viral
- Spike Glycoprotein, Coronavirus
- Viral Vaccines